Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma
Clinical trial NCT04570657 · COMPLETED
Trial details
- NCT number
- NCT04570657
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2022-12-12
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.